We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BD1 market cap is 95.24M. The company's latest EPS is AUD -0.0975 and P/E is -5.33.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 571k | 71k | 1.43M | 2M | 1.55M |
| Operating Income | -1.73M | -3.36M | -13.86M | -20.32M | -9.32M |
| Net Income | -1.72M | -3.25M | -11.15M | -18.2M | -8.97M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 7.63M | 7.37M | 33.52M | 30.78M | 21.51M |
| Total Liabilities | 492k | 899k | 4.47M | 2.49M | 1.89M |
| Total Equity | 7.14M | 6.48M | 29.06M | 28.29M | 19.62M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.57M | -2.54M | -5.26M | -6.06M | -7.03M |
| Investing | N/A | N/A | 2.98M | -412k | -292k |
| Financing | 7.68M | 2.31M | -49k | 16.88M | -268k |
| Market Cap | 95.24M |
| Price to Earnings Ratio | -5.33 |
| Price to Sales Ratio | 30.77 |
| Price to Cash Ratio | 6.12 |
| Price to Book Ratio | 2.44 |
| Dividend Yield | - |
| Shares Outstanding | 92.02M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.05 (4.19%) |
| Company Name | Bard1 Life Sciences Limited |
| Address |
23 normanby road melbourne, victoria 3168 |
| Website | https://www.bard1.com |
| Industry | finance services (6199) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
